The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment. Researchers will compare Phonomotor Treatment and Phonological Components Analysis to see which treatment is more beneficial, and for whom. Participants will engage in both treatments over several months.

Participants will complete screening and characterization testing to determine eligibility for the study. Each treatment will be administered twice a week, for 10-15 sessions. Pre-treatment and post-treatment testing will also occur for each treatment. There will be a period of no treatment in between the first and second treatment blocks.

Inclusion Criteria:

• Chronic aphasia (6+ months)
• Anomia
• Sufficient auditory comprehension to follow task instructions
• Phonologic impairment

Exclusion Criteria:

• Progressive neurological illness or disease, including dementia
• Chronic medical illness that interferes with adherence to testing schedule
• Severe, uncorrected vision or hearing impairment that interferes with task completion
• Moderate-severe apraxia of speech or dysarthria that interferes with task completion

Sample size is low increasing risk of identification of individuals.